Jiang et al., 2021 - Google Patents
Gut microbiota may play a significant role in the pathogenesis of Graves' diseaseJiang et al., 2021
View PDF- Document ID
- 1890776371122483810
- Author
- Jiang W
- Yu X
- Kosik R
- Song Y
- Qiao T
- Tong J
- Liu S
- Fan S
- Luo Q
- Chai L
- Lv Z
- Li D
- Publication year
- Publication venue
- Thyroid
External Links
Snippet
Background: Gut microbiota are considered to be intrinsic regulators of thyroid autoimmunity. We designed a cross-sectional study to examine the makeup and metabolic function of microbiota in Graves' disease (GD) patients, with the ultimate aim of offering new …
- 206010004161 Basedow's disease 0 title abstract description 100
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Jiang et al. | Gut microbiota may play a significant role in the pathogenesis of Graves' disease | |
| Visconti et al. | Interplay between the human gut microbiome and host metabolism | |
| Wauters et al. | Efficacy and safety of spore-forming probiotics in the treatment of functional dyspepsia: a pilot randomised, double-blind, placebo-controlled trial | |
| Dieterich et al. | Influence of low FODMAP and gluten-free diets on disease activity and intestinal microbiota in patients with non-celiac gluten sensitivity | |
| Cignarella et al. | Intermittent fasting confers protection in CNS autoimmunity by altering the gut microbiota | |
| Jones et al. | Probiotic supplementation increases obesity with no detectable effects on liver fat or gut microbiota in obese Hispanic adolescents: a 16‐week, randomized, placebo‐controlled trial | |
| Yan et al. | Gut microbiota alterations in moderate to severe acne vulgaris patients | |
| Dang et al. | Assessing the efficacy and safety of fecal microbiota transplantation and probiotic VSL# 3 for active ulcerative colitis: A systematic review and meta-analysis | |
| Wang et al. | Children with atopic dermatitis show clinical improvement after Lactobacillus exposure | |
| Seppo et al. | Infant gut microbiome is enriched with Bifidobacterium longum ssp. infantis in Old Order Mennonites with traditional farming lifestyle | |
| Scheepers et al. | The intestinal microbiota composition and weight development in children: the KOALA Birth Cohort Study | |
| Zambrana et al. | Rice bran supplementation modulates growth, microbiota and metabolome in weaning infants: a clinical trial in Nicaragua and Mali | |
| Hill et al. | Expert consensus document: The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic | |
| Murphy et al. | Composition and energy harvesting capacity of the gut microbiota: relationship to diet, obesity and time in mouse models | |
| Fritsch et al. | The microbiota and the immune response: what is the chicken and what is the egg? | |
| Harnett et al. | Probiotics and the microbiome in celiac disease: a randomised controlled trial | |
| Losurdo et al. | The interaction between celiac disease and intestinal microbiota | |
| Hiergeist et al. | Clinical implications of the microbiome in urinary tract diseases | |
| Sato et al. | Type 2 diabetes and bacteremia | |
| Cui et al. | Different effects of three selected Lactobacillus strains in dextran sulfate sodium-induced colitis in BALB/c mice | |
| Bulik-Sullivan et al. | Intestinal microbial and metabolic alterations following successful fecal microbiota transplant for D-lactic acidosis | |
| Cabrera et al. | Probiotic normalization of systemic inflammation in siblings of type 1 diabetes patients: an open-label pilot study | |
| Sila et al. | Altered gut microbiota is present in newly diagnosed pediatric patients with inflammatory bowel disease | |
| Yang et al. | Probiotics partially attenuate the severity of acute kidney injury through an immunomodulatory effect | |
| Driuchina et al. | Identification of gut microbial lysine and histidine degradation and CYP-dependent metabolites as biomarkers of fatty liver disease |